Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Aug;69(2):420–425.

Binding of adenosine and receptor-specific analogues to lymphocytes from control subjects and patients with common variable immunodeficiency.

T Shah 1, R J Simpson 1, A D Webster 1, T J Peters 1
PMCID: PMC1542397  PMID: 2958197

Abstract

Studies were performed on the binding of tritiated adenosine and its analogues, 5'-N-ethylcarboxamide adenosine (NECA) and N6-phenylisopropyladenosine (PIA), to human peripheral blood lymphocytes. These revealed binding only of adenosine (Kd, 1-10 microM, 14,000 binding sites/cell), which was abolished by dipyridamole, a specific adenosine transport inhibitor, suggesting that the binding is to the nucleoside transporter. The absence of high affinity (Kd less than or equal to 1 microM) binding of adenosine or of the two analogues. NECA and PIA suggests that the previously reported effects of adenosine on cAMP formation are not mediated by cell surface specific nucleoside receptors. Binding of adenosine to the carrier in lymphocytes from patients with common variable immunodeficiency was similar to those from control subjects.

Full text

PDF
420

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonnafous J. C., Dornand J., Favero J., Mani J. C. Lymphocyte membrane adenosine receptors coupled to adenylate cyclase: properties and occurrence in various lymphocyte subclasses. J Recept Res. 1981;2(4):347–366. doi: 10.3109/107998981809038872. [DOI] [PubMed] [Google Scholar]
  2. Bonnafous J. C., Dornand J., Mani J. C. Hormone-like action of adenosine in mouse thymocytes and splenocytes: Evidence for the existence of membrane adenosine receptors coupled to adenylate cyclase. FEBS Lett. 1979 Nov 1;107(1):95–99. doi: 10.1016/0014-5793(79)80471-8. [DOI] [PubMed] [Google Scholar]
  3. Cuatrecasas P. Insulin--receptor interactions in adipose tissue cells: direct measurement and properties. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1264–1268. doi: 10.1073/pnas.68.6.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Henderson J. F. Inhibition of microbial growth by naturally-occurring purine bases and ribonucleosides. Pharmacol Ther. 1980;8(3):605–627. doi: 10.1016/0163-7258(80)90078-9. [DOI] [PubMed] [Google Scholar]
  5. Hüttemann E., Ukena D., Lenschow V., Schwabe U. Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity. Naunyn Schmiedebergs Arch Pharmacol. 1984 Mar;325(3):226–233. doi: 10.1007/BF00495948. [DOI] [PubMed] [Google Scholar]
  6. Londos C., Cooper D. M., Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980 May;77(5):2551–2554. doi: 10.1073/pnas.77.5.2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Londos C., Wolff J. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5482–5486. doi: 10.1073/pnas.74.12.5482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Marone G., Plaut M., Lichtenstein L. M. Characterization of a specific adenosine receptor on human lymphocytes. J Immunol. 1978 Dec;121(6):2153–2159. [PubMed] [Google Scholar]
  9. Pickard M. A., Brown R. R., Paul B., Paterson A. R. Binding of the nucleoside transport inhibitor 4-nitrobenzylthioinosine to erythrocyte membranes. Can J Biochem. 1973 May;51(5):666–672. doi: 10.1139/o73-083. [DOI] [PubMed] [Google Scholar]
  10. Saxon A., Thiele C. J., Moroz C., Stevens R. H. Adenosine receptor lymphocytes in humoral immunodeficiency. J Clin Immunol. 1981 Apr;1(2):131–136. doi: 10.1007/BF00915391. [DOI] [PubMed] [Google Scholar]
  11. Schwartz A. L., Stern R. C., Polmar S. H. Demonstration of adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency. Clin Immunol Immunopathol. 1978 Apr;9(4):499–505. doi: 10.1016/0090-1229(78)90146-0. [DOI] [PubMed] [Google Scholar]
  12. Shah T., Webster A. D., Peters T. J. Enzyme analysis and subcellular fractionation of human peripheral blood lymphocytes with special reference to the localization of putative plasma membrane enzymes. Cell Biochem Funct. 1983 Jul;1(2):117–124. doi: 10.1002/cbf.290010214. [DOI] [PubMed] [Google Scholar]
  13. Shah T., Webster A. D., Peters T. J. Kinetic properties of 5' nucleotidase in blood lymphocytes from healthy subjects, immunodeficient patients and cord blood. Clin Exp Immunol. 1984 Jul;57(1):149–154. [PMC free article] [PubMed] [Google Scholar]
  14. Shah T., Webster A. D., Peters T. J. Lymphocyte enzyme activities in immunodeficiency syndromes with particular reference to common variable hypogammaglobulinaemia. Clin Exp Immunol. 1983 Aug;53(2):413–422. [PMC free article] [PubMed] [Google Scholar]
  15. Smith G. P., Shah T., Webster A. D., Peters T. J. Studies on the kinetic properties and subcellular localization of adenine nucleotide phosphatases in peripheral blood lymphocytes from control subjects and patients with common variable primary hypogammaglobulinaemia. Clin Exp Immunol. 1982 Aug;49(2):393–400. [PMC free article] [PubMed] [Google Scholar]
  16. Stone T. W. Cell-membrane receptors for purines. Review. Biosci Rep. 1982 Feb;2(2):77–90. doi: 10.1007/BF01116173. [DOI] [PubMed] [Google Scholar]
  17. Van der Weyden M. B., Kelley W. N. Adenosine deaminase and immune function. Br J Haematol. 1976 Oct;34(2):159–165. doi: 10.1111/j.1365-2141.1976.tb00187.x. [DOI] [PubMed] [Google Scholar]
  18. van Calker D., Müller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979 Nov;33(5):999–1005. doi: 10.1111/j.1471-4159.1979.tb05236.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES